Citation 74049

ASANO,N: KATO,A: OSEKI,K: KIZU,H: MATSUI,K:. (1995). CALYSTEGINS OF PHYSALIS ALKEKENGI VAR.FRANCHETI (SOLANACEAE) STRUCTURE DETERMINATION AND THEIR GLYCOSIDASE INHIBITORY ACTIVITIES.. 229(2)

Citation Details

TitleCALYSTEGINS OF PHYSALIS ALKEKENGI VAR.FRANCHETI (SOLANACEAE) STRUCTURE DETERMINATION AND THEIR GLYCOSIDASE INHIBITORY ACTIVITIES.
AuthorsASANO,N: KATO,A: OSEKI,K: KIZU,H: MATSUI,K:
Year1995
Volume229
Issue2

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Physalis alkekengi (SOLANACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
CALYSTEGINE B-2
None
2
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE B-2
ACTIVE
3
ALPHA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE B-2
ACTIVE
4
BETA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE B-2
WEAK ACTIVITY
5Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
CALYSTEGINE A-3
None
6Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CALYSTEGINE A-5
None
7
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE A-3
WEAK ACTIVITY
8
ALPHA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE A-3
WEAK ACTIVITY
9
BETA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE A-3
WEAK ACTIVITY
10
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE A-5
INACTIVE
11
ALPHA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE A-5
INACTIVE
12
BETA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE A-5
INACTIVE
13Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CALYSTEGINE B-3
None
14Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
CALYSTEGINE B-1
None
15
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE B-3
EQUIVOCAL
16
ALPHA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE B-3
INACTIVE
17
BETA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE B-3
INACTIVE
18
BETA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE B-1
ACTIVE
19
ALPHA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE B-1
INACTIVE
20
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE B-1
ACTIVE
21Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
CALYSTEGINE C-1
None
22
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE C-1
ACTIVE
23
ATP-ASE(CA++/MG++) STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE C-1
WEAK ACTIVITY
24
BETA-GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CALYSTEGINE C-1
ACTIVE
Show SPARQL Queries (1)